Lifeline Biotechnologies chairman and CEO Jim Holmes said the issuance of patent has taken considerable effort to reach the conclusion of a milestone that started with the company’s clinical trials and a patent filing on 27 August 2008.
"We knew our core science charted new territory and was unique because it took considerable resources to achieve our results," Holmes added.
"The foundation of this Company is our two issued patents (developed data collection device and the software patent above referenced) together with two pending patents (a software patent and a methods patent).
"Based on this intellectual property, we are supporting our licensee, First Warning Systems, Inc. in moving ahead with investment and commercialization plans."
